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[Abstract] Secondary active transport of substrates across the inner membrane is vital to the 11 
bacterial cell. Of the secondary active transporter families, the ubiquitous major facilitator superfamily 12 
(MFS) is the largest and most functionally diverse (Reddy et al., 2012). Recently, it was reported that 13 
the MFS multidrug efflux protein MdtM from Escherichia coli functions physiologically in protection of 14 
bacterial cells against bile salts (Paul et al., 2014). The MdtM transporter imparts bile salt resistance 15 
to the bacterial cell by coupling the exchange of external protons (H+) to the efflux of bile salts from 16 
the cell interior via an antiport reaction. This protocol describes, using fluorometry, how to detect the 17 
bile salt/H+ antiport activity of MdtM in inverted membrane vesicles of an antiporter-deficient strain of 18 
E. coli TO114 cells by measuring transmembrane ∆pH. This method exploits the changes that occur 19 
in the intensity of the fluorescence signal (quenching and dequenching) of the pH-sensitive dye 20 
acridine orange in response to changes in [H+] in the vesicular lumen. Due to low levels of 21 
endogenous transporter expression that would normally make the contribution of individual 22 
transporters such as MdtM to proton-driven antiport difficult to detect, the method typically 23 
necessitates that the transporter of interest be overexpressed from a multicopy plasmid. Although the 24 
protocol described here pertains to measurement of bile salt efflux by a specific membrane 25 
transporter protein (MdtM), it can be easily adapted for measurement of antiport of other substrates 26 
by any other antiporter that exchanges protons for countersubstrate. We have therefore omitted 27 
description of the bacterial growth and protein overexpression conditions (as these are usually 28 
different for every membrane protein), and begin the procedure from the point of harvesting of 1 L 29 
cultures of bacterial cells enriched with plasmid-encoded antiporter. 30 
 31 
Materials and Reagents 32 
 33 
1. Escherichia coli (E. coli) TO114 cells (gift of Prof. Hiroshi Kobayashi, Chiba University, Japan) 34 
2. Acridine orange hemi (zinc chloride) salt (Sigma-Aldrich, catalog number: A6014) 35 
3. BisTris propane (BTP) (Sigma-Aldrich, catalog number: B6755) 36 
4. Phenylmethanesulfonyl fluoride (PMSF) (Sigma-Aldrich, catalog number: P7626) 37 
5. Deoxyribonuclease I (DNase) from bovine pancreas (Sigma-Aldrich, catalog number: DN25) 38 
6. Carbonyl cyanide 3-chlorophenylhydrazone (CCCP) (Sigma-Aldrich, catalog number: C2759) 39 
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7. Sodium DL-lactate solution 50% aqueous (VWR International, catalog number: 27927.298) 40 
8. Magnesium sulphate heptahydrate (MgSO4.7H2O) (Thermo Fisher Scientific, catalog number: 41 
M/1000/60) 42 
9. Sodium cholate hydrate (Sigma-Aldrich, catalog number: C1254) 43 
10. Absolute ethanol (Thermo Fisher Scientific, catalog number: E/0650DF/17) 44 
11. High purity (18 M) Millipore or AnalR water 45 
12. Choline chloride (Sigma-Aldrich, catalog number: C1879) 46 
13. Sucrose (Sigma-Aldrich, catalog number: 84097) 47 
14. DL-dithiothreitol (Sigma-Aldrich, catalog number: 43815) 48 
15. TRIZMA base (Sigma-Aldrich, catalog number: T1503) 49 
16. 32% hydrochloric acid  (VWR International, catalog number: 20254.321) 50 
17. Tris/choline/dithiothreitol/sucrose (TCDS) buffer (see Recipes) 51 
18. Transport assay buffer (see Recipes)  52 
19. 200 mM sodium DL-lactate solution (see Recipes) 53 
 54 
Equipment 55 
 56 
1. Temperature-controlled shaking incubator for bacterial growth 57 
2. Large ice bucket 58 
3. Refrigerated, large capacity centrifuge and rotor for harvesting bacterial cells 59 
4. 1,000 ml or 500 ml centrifuge pots and lids 60 
5. Benchtop vortexer 61 
6. 100 ml conical flask 62 
7. 100 ml beaker and stir bar to fit 63 
8. Magnetic stirrer 64 
9. 25 ml disposable plastic pipettes 65 
10. Selection of single channel pipettes (1,000 µl, 100 µl, 20 µl, 10 µl) 66 
11. Pipette tips for above 67 
12. Refrigerated centrifuge and rotor capable of spinning ~50 ml tubes at 18k x g 68 
13. Refrigerated ultracentrifuge, rotor and polycarbonate ultracentrifuge tubes capable of handling 69 
~30 - 50 ml volumes 70 
14. French Press (Thermo Fisher Scientific, catalogue number: FA-078) 71 
15. Standard pressure cell (40 kpsi; 35 ml capacity) (Thermo Fisher Scientific, catalog number: 72 
FA-031) 73 
16. 50 ml syringes (for filtering solutions) 74 
17. 0.22 µm sterile filters to fit 50 ml syringe 75 
18. 1 L and 500 ml Duran bottles with lids 76 
19. 1.5 ml Eppendorf tubes 77 
20. Medical wipes (Kimwipes®) 78 
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21. Parafilm 79 
22. UV/vis spectrophotometer and 10 mm pathlength quartz cuvette 80 
23. 10 x 4 mm, 1,400 µl volume quartz cuvette for fluorescence spectroscopy (Hellma, catalog 81 
number: 104F-QG) 82 
24. Small magnetic stir bar to fit inside quartz cuvette 83 
25. Fluorometer e.g. Fluoromax-4 (Horiba) capable of performing time-based acquisition 84 
measurements and fitted with a temperature controlled cuvette holder and stirrer 85 
26. Source of compressed air (either aerosol can or fixed supply) for drying cuvette 86 
 87 
Procedure 88 
 89 
A. Harvesting bacterial cultures and preparation of inverted membrane vesicles 90 
1. Transfer the E. coli TO114 cells that contain overexpressed transporter into 500 ml or 1,000 91 
ml capacity centrifuge pots that have been pre-chilled on ice for at least 15 mins.  Pre-cool the 92 
centrifuge to 4 C and harvest cells by centrifugation at 5,000 x g for 20 min.  93 
2. Decant the supernatant and wash the pelleted cells by resuspending in chilled (4 C) TCDS 94 
buffer. Use 30 ml of TCDS buffer for each one litre of cell culture that was pelleted. Maintain 95 
the cells on ice during this procedure. Harvest the washed cells by centrifugation as described 96 
in step A1 (above) and repeat the washing procedure. Resuspend the resultant cell pellet in 97 
30 ml of chilled TCDS buffer containing 2 mM PMSF (Which should be made up as a 100 mM 98 
stock in ethanol and stored at -20 C; ensure the solution is thawed thoroughly and vortexed 99 
vigorously before use.) and 5 µM DNase and maintain the mixture on ice. 100 
Notes: 101 
a. Typically, a 1 L culture of bacterial cells will provide sufficient material for these 102 
experiments. 103 
b. Cells should be resuspended either by gentle vortexing using a benchtop vortexer or by 104 
gentle aspiration using a 25 ml sterile plastic pipette. 105 
3. Decant the resuspended cells into a 100 ml beaker containing a stir bar, place on magnetic 106 
stirrer and stir in a cold room at 4 C or on ice for 20 min. 107 
4. Generate inverted membrane vesicles by a single passage of the resuspended cell mixture 108 
through a French pressure cell at a minimum of 4,000 psi. If the pressure is too low, inverted 109 
vesicles will not be formed. The pressure cell should be chilled on ice for ~30 min prior to use. 110 
The vesicle mixture should be collected in a 100 ml conical flask kept on ice. 111 
5. Decant the mixture into a pre-chilled ~50 ml centrifuge tube and remove any unbroken cells 112 
and cell debris by centrifugation at 18,000 x g for 10 min at 4 C. Carefully decant the 113 
supernatant containing the cell membrane vesicles into a pre-chilled 30-50 ml volume 114 
polycarbonate ultracentrifuge tube on ice. 115 
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6. Harvest the inverted vesicles by ultracentrifugation at 100,000 x g for 1 h at 4 C. Carefully 116 
decant the supernatant and retain the pellet. Place the ultracentrifuge tube containing the 117 
pelleted vesicles on ice. 118 
7. Resuspend the inverted vesicle pellet in 1 ml of ice-cold TCDS buffer by gentle aspiration 119 
using a 1,000 µl pipette. Transfer the resuspended vesicles to a pre-chilled 1.5 ml Eppendorf 120 
tube on ice for use in the transport assay. In our experience, vesicles stored on ice are stable 121 
for several hours. 122 
8. Quantify the total membrane protein content of the inverted vesicles by UV absorbance 123 
spectroscopy at 280 nm. Blank the spectrophotometer using a 10 mm pathlength quartz 124 
cuvette containing 1,000 µl of TCDS buffer. The buffer should be at room temperature to 125 
prevent frosting of the cuvette faces. Clean the faces of the cuvette using a fresh paper wipe 126 
prior to measurement. Once the spectrophotometer is blanked, remove 5 µl of buffer from the 127 
cuvette using a 10 µl pipette and replace with 5 µl of vesicles. Cover the opening of the 128 
cuvette with a square of Parafilm and invert the cuvette a few times to ensure a 129 
homogeneous distribution of vesicles. Record the absorbance of the vesicle mixture at 280 130 
nm and calculate the total membrane protein concentration assuming that an A280 of 1.0 is 131 
equivalent to a protein concentration of 1.0 mg/ml. 132 
Notes: 133 
a. Remember to multiply the 280 nm absorbance value you obtain by a factor of 200 to 134 
calculate the concentration of the undiluted vesicle mixture in mg/ml. 135 
b. At this stage of the preparation, the resuspended vesicles can be transferred to tubes in 136 
aliquots of 25-100 µl, snap-frozen in liquid nitrogen and stored at -80 C for subsequent 137 
use. Vesicles frozen in this way will retain their integrity for several months. However, if 138 
frozen vesicle stocks are used for the subsequent transport measurements, the vesicles 139 
must be thawed very slowly on ice prior to use to prevent their fracture.   140 
 141 
B. Fluorometric antiport assays 142 
1. In this section we describe the set-up parameters for a Fluoromax-4 fluorometer. These 143 
parameters, however, can form the basis for the set-up of other fluorometers. Once the 144 
instrument is switched on and the software booted up, set the temperature of the cuvette 145 
holder to 25 C. Open the instrument software and select for time-based data acquisition with 146 
excitation and emission wavelengths of 492 nm and 525 nm, respectively. Set the excitation 147 
and emission slit widths to 1.5 nm and 2.5 nm, respectively. 148 
2. Add an aliquot of inverted vesicles (which should be maintained on ice in TCDS buffer) to 149 
room temperature transport assay buffer containing the acridine orange probe in a 10 mm x 4 150 
mm quartz cuvette to a final concentration of 0.5 mg/ml membrane protein in a total volume of 151 
1,500 µl.  The longest pathlength of the cuvette should face the excitation light source. Place 152 
a small magnetic flea into the cuvette and stir the contents gently. Allow the vesicles and 153 
assay buffer to equilibrate for ~200 sec. 154 
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3. Start recording the fluorescence emission. After approximately 50 sec, add 15 µl of 200 mM 155 
stock sodium DL-lactate solution to the cuvette contents to give a final sodium DL-lactate 156 
concentration of ~2.0 mM. Addition of lactate energises the vesicles and generates a 157 
respiration dependent pH (acid inside) across the inverted vesicle membrane as H+ is 158 
pumped into the vesicle interior. This causes a dequench of the acridine orange fluorescence 159 
signal (see Figure 1in Representative data). 160 
4. Following the establishment of a pH, monitor the acridine orange fluorescence dequench for 161 
a further ~200 sec until it stabilises. Initiate MdtM-mediated, proton-driven antiport by adding 162 
substrate (in this case the bile salt sodium cholate) to the inverted vesicle mixture. We added  163 
12.5 µl of 250 mM stock solution made up in high purity water to give a final concentration of 164 
sodium cholate in the cuvette of ~2.0 mM. For other substrates we suggest testing a range 165 
varying from 1 mM to 100 mM to establish the concentration that gives the best dequench 166 
signal. Upon addition of substrate, there should be an immediate dequench (rise) of the 167 
acridine orange fluorescence emission signal (see Figure 1a) due to dissipation of the 168 
established ∆pH as a result of MdtM-mediated sodium cholate/H+ antiport activity and 169 
concomitant alkalinisation of the vesicle lumen. 170 
5. Record the fluorescence dequench signal for 50 sec to allow the antiport reaction to achieve a 171 
steady state (as observed by a plateauing of the fluorescence signal). Addition of the 172 
protonophore CCCP to a final concentration of ~100 µM (1.6 µl of a 100 mM stock made up in 173 
ethanol) in the assay mixture should be performed to abolish ∆pH-driven, MdtM-mediated 174 
antiport activity. Addition of CCCP will cause a further dequench of the fluorescence signal as 175 
the ∆pH is dissipated (see Figure 1). Record the fluorescence signal for a further ~50 sec 176 
then terminate the acquisition and save the electronic data. 177 
6. Decant the cuvette contents into a suitable waste container and wash the cuvette thoroughly 178 
with ethanol then high-purity water. Dry the cuvette carefully with compressed air. 179 
 180 
Representative data 181 
 182 
 183 
Figure 1. Representative measurements of the fluorescence quench/dequench of acridine 184 
orange upon addition of bile salts to inverted vesicles of E. coli TO114 cells that 185 
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overproduced recombinant (a) wild type MdtM or, as a control, (b) the dysfunctional MdtM 186 
D22A mutant. Respiration-dependent generation of pH (acid inside) was established by addition 187 
of sodium DL-lactate as indicated. Sodium cholate was added to vesicles as indicated to initiate 188 
the transport reaction and CCCP was used to dissipate pH. The fluorescence dequench 189 
observed in the control experiment (panel b) upon addition of sodium cholate is due to antiport 190 
activity of chromosomally encoded MdtM. The traces are representative of experiments 191 
performed in triplicate on at least two separate preparations of inverted vesicles. 192 
 193 
Notes 194 
 195 
a. To ensure reproducibility, the assays should be performed in triplicate on at least two 196 
separate preparations of inverted vesicles. 197 
b. If the fluorescence signal does not quench, or enhances, the vesicles have either not 198 
maintained integrity or are not inverted and their preparation needs to be repeated. 199 
c. As with all assays that rely on detection of fluorescence, robust controls must be in place 200 
to ensure that any detected transport activity can be attributed unambiguously to the 201 
protein of interest. In our experiments, we used inverted vesicles that overexpressed 202 
MdtM D22A, a dysfunctional point mutant of MdtM, as a negative control (see Figure 1b). 203 
d. If the method is to be used for detection of metal ion/H+ antiport activity, the use of 204 
inverted vesicles generated from the antiporter-deficient TO114 strain of E. coli is 205 
important because at least four other transporters (NhaA, NhaB, ChaA and MdfA) present 206 
in the bacterium catalyse a monovalent metal cation/H+ exchange. 207 
e. Finally, if this protocol is used for comparison of antiport activities of wild type and mutant 208 
transporters, the amount of target protein present in the inverted vesicle membranes must 209 
be quantified (usually by immunodetection methods) to ensure that any measured 210 
differences in H+ uptake are due solely to differences in the activity of the transporters 211 
and not to differences in expression levels. 212 
 213 
Recipes 214 
 215 
1. Tris/choline/dithiothreitol/sucrose (TCDS) buffer (1 L)  216 
Consisting of 10 mM Tris-HCl (pH 7.5), 140 mM choline chloride, 0.5 mM dithiothreitol and 217 
250 mM sucrose 218 
1 M Tris-HCl (pH 7.5) 10 ml 219 
2 M choline chloride 70 ml 220 
1 M sucrose 250 ml 221 
Make up to 999.5 ml with high purity water then check pH and adjust if necessary with HCl 222 
Autoclave or sterile filter and store at 4 C 223 
Add 0.5 ml dithiothreitol from frozen 1 M stocks immediately before use 224 
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2. Transport assay buffer (100 ml)  225 
Consisting of 10 mM BisTris propane (pH 7.2), 5 mM MgSO4, 1 µM acridine orange 226 
100 mM BisTris propane (pH 7.2) 10 ml 227 
2 M MgSO4 0.25 ml 228 
10 mM acridine orange 10 µl 229 
Make up to 100 ml with high purity water then sterile filter  230 
Acridine orange is light sensitive so both the transport assay buffer and acridine orange 231 
stocks should be stored either in amber bottles or in a container protected from light at 4 C in 232 
the dark. 233 
3. 200 mM sodium DL-lactate solution (10 ml) 234 
0.45 ml 50% sodium DL-lactate aqueous solution 235 
Make up to 10 ml with high-purity water 236 
Sterile filter and stored at 4 C 237 
 238 
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